Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: The Japanese Musculoskeletal Oncology Group study

Journal of Clinical Oncology

Volumn 20, Issue 16, 2002, Pages 3470-3477

  Tsuchiya, Hiroyuki ^a   Kanazawa, Yoshimitsu ^a   Abdel Wanis, Mohamed E ^a   Asada, Naohiro ^a   Abe, Satoshi ^a   Isu, Kazuo ^a   Sugita, Takashi ^a   Tomita, Katsuro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DECISION MAKING; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0037102214     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.11.028     Document Type: Article

References (40)

1. Osteogenic sarcoma with clinically detectable metastasis at initial presentation
2. Prognostic factor studies in oncology: Osteosarcoma as a clinical example
3. Patterns of recurrence after resection of osteosarcoma of the extremity: Strategies for treatment of metastases
4. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases
5. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
6. Survival, prognosis, and therapeutic response in osteogenic sarcoma: The Memorial Hospital experience
7. Osteosarcoma chemotherapy effect: A prognostic factor
8. Marginal excision for osteosarcoma with caffeine assisted chemotherapy
9. Chemotherapy and thoracotomy for metastatic osteogenic sarcoma: A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery
10. Resection of pulmonary metastatic osteogenic sarcoma in children
11. Surgical treatment of pulmonary metastases
12. The surgical management of pulmonary metastases
13. Metastatic patterns osteosarcoma
14. Pulmonary metastases in children: The place of surgery-A study of 134 patients
15. Resection of pulmonary metastases in osteosarcoma: A retrospective analysis of 44 patients
16. Aggressive pulmonary resection for metastatic osteogenic and soft tissue sarcomas
17. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: Analysis of 32 patients
18. The influence of tumor microfoci on recurrence and survival following pulmonary resection of metastatic osteogenic sarcoma
19. Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents
20. Pulmonary resection for metastatic sarcoma
21. Rationale for the surgical treatment of pulmonary metastases
22. Thoracotomy for pulmonary metastatic osteosarcoma: An analysis of prognostic indicators of survival
23. Surgical resection for metastatic neoplasms of the lung: Experience at the University of Minnesota hospitals
24. Lung resection for metastatic sarcomas: Total survival from primary treatment
25. Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: Analysis of prognogtic factors
26. Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients
27. Thoracotomy as adjuvant to chemotherapy in metastatic osteogenic sarcoma
28. Pulmonary resection for metastatic osteogenic sarcoma
29. Multiple pulmonary resections in the treatment of osteogenic sarcoma
30. Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal
31. A system of staging musculoskeletal neoplasms
32. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
33. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma
34. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay
35. Relation between histological intensity of transforming growth factor-beta isoforms in human osteosarcoma and the rate of lung metastasis
36. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogenic peripheral-blood stem-cell transplantation
37. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma
38. In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy
39. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p 53 gene in human osteosarcoma
40. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma